MARKET

LEGN

LEGN

Legend Biotech Corp
NASDAQ
17.56
-0.29
-1.62%
Opening 10:58 03/05 EST
OPEN
17.65
PREV CLOSE
17.85
HIGH
17.82
LOW
17.48
VOLUME
280.29K
TURNOVER
--
52 WEEK HIGH
45.30
52 WEEK LOW
16.24
MARKET CAP
3.24B
P/E (TTM)
-13.4880
1D
5D
1M
3M
1Y
5Y
1D
Artisan International Small-Mid Fund Q4 2025 Performance Review
Seeking Alpha · 3d ago
Weekly Report: what happened at LEGN last week (0223-0227)?
Weekly Report · 3d ago
Legend Biotech Corporation to Host Investor Conference Call on Fourth-Quarter and Full-Year 2025 Results
Reuters · 02/24 13:03
Legend Biotech: Undervalued BCMA CAR-T Leader with Lower Commercial Risk and DCF-Supported Upside to $50 Target
TipRanks · 02/24 11:16
What Gilead Is Getting Through The Acquisition Of Arcellx
Seeking Alpha · 02/23 16:46
Legend Biotech rises 16.6%
TipRanks · 02/23 15:07
ImmunityBio Posts Upbeat Q4 Earnings, Joins Arcellx, Vanda Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Benzinga · 02/23 15:03
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 02/23 12:05
More
About LEGN
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.

Webull offers Legend Biotech Corp (ADR) stock information, including NASDAQ: LEGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEGN stock methods without spending real money on the virtual paper trading platform.